Preoperative Blood Volume Optimization Using Transthoracic Echocardiography

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-99
SponsorUniversity Hospital, Caen

About this trial

Immediately following the induction of general anesthesia, arterial hypotension may occur with an incidence of about 40% in patients classified as ASA 3 or 4. Perioperative arterial hypotension is associated with increased perioperative morbidity and mortality. The increased mortality associated with perioperative arterial hypotension has been reported up to 30 and 90 days after surgery. This association appears to be both dose-dependent and time-dependent (severity and duration of arterial hypotension).

EchOptimal study aims to determine whether non invasive preoperative stroke volume optimization using transthoracic echocardiography (TTE) can reduce the incidence and severity arterial hypotension following induction of general anesthesia.

This is prospective, randomized, controlled, double blinded study approved by ethics comittee.

The primary objective of this study is to compare the incidence of arterial hypotension (mean arterial pressure \< 65 mmHg) within the first 15 minutes following the induction of general anesthesia, between 2 groups :

* standard current care (stroke volume optimized after induction of general anesthesia using oesophageal doppler) and * preopertaive stroke volume optimization using transthoracic echocardiography measument of subaortic velocity time integral.

Eligibility criteria

Qualifiers

Patient aged 18 years or older,

Affiliated with social security,

Informed about the study and having signed the informed consent form,

Requires surgical intervention under general anesthesia,

Disqualifiers

Patients under guardianship, curatorship, judicial protection, or legal protection,

Minors,

Patients with contraindications to intravenous induction with Propofol and Remifentanil,

Patients not fasting at the time of surgery,

Trial design

Treatments tested in this trial

  • preoperative stroke volume optimization
  • Post induction stroke volume optimization

Treatment groups

220 Participants
are divided into 2 treatment groups

Sponsors and collaborators